Publications by authors named "M L McCord"

Purpose: Glioblastoma (GBM) that presents as leptomeningeal disease (LMD) is extremely rare and fatal. Limited data are available regarding incidence, clinical presentation, and management. Prognosis is poor and no treatment is known to improve survival.

View Article and Find Full Text PDF
Article Synopsis
  • Acquired resistance to temozolomide (TMZ) in glioblastoma patients, particularly those with DNA mismatch repair deficiencies, limits treatment effectiveness, prompting research into the new drug KL-50, which targets cancer cells in an MMR-independent manner.
  • In studies, KL-50 significantly improved the median survival of mice with both naive and post-TMZ glioblastoma xenografts, showcasing its potential as a superior treatment option.
  • Results indicate KL-50 may be particularly effective in MGMT and MMR-deficient tumors, offering hope for better management of recurrent glioblastoma after initial TMZ therapy.
View Article and Find Full Text PDF
Article Synopsis
  • The Pediatric Academic Societies highlight the importance of incorporating Community Health Workers (CHWs) in well-child care for low-income families, emphasizing their community trust and cultural relevance.
  • Integrating CHWs can alleviate pressure on clinicians by handling certain well-child care services, enhancing preventive care during crucial early childhood development.
  • Successful implementation requires collaboration among health systems, flexible adaptations to fit local needs, accessible training resources for CHWs, and research to inform best practices and payment models.
View Article and Find Full Text PDF

Here, we summarise the extinction risk of the sharks and rays endemic to coastal, shelf, and slope waters of the southwest Indian Ocean and adjacent waters (SWIO+, Namibia to Kenya, including SWIO islands). This region is a hotspot of endemic and evolutionarily distinct sharks and rays. Nearly one-fifth (n = 13 of 70, 18.

View Article and Find Full Text PDF

Background: Post-endoscopy upper gastrointestinal cancer (PEUGIC) is an important key performance indicator for endoscopy quality. We examined variation in PEUGIC rates among endoscopy providers in England and explored associated factors.

Methods: The was a population-based, retrospective, case-control study, examining data from National Cancer Registration and Analysis Service and Hospital Episode Statistics databases for esophageal and gastric cancers diagnosed between 2009 and 2018 in England.

View Article and Find Full Text PDF